These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8883615)

  • 1. Cellular immune responses to HIV-1 in progressive and non-progressive infections.
    Bollinger RC; Egan MA; Chun TW; Mathieson B; Siliciano RF
    AIDS; 1996; 10 Suppl A():S85-96. PubMed ID: 8883615
    [No Abstract]   [Full Text] [Related]  

  • 2. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.
    Yang OO; Walker BD
    Adv Immunol; 1997; 66():273-311. PubMed ID: 9328644
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.
    Jassoy C; Walker BD
    Springer Semin Immunopathol; 1997; 18(3):341-54. PubMed ID: 9089953
    [No Abstract]   [Full Text] [Related]  

  • 4. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
    Rivière Y
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune control of HIV-1 replication.
    Walker BD; Rosenberg ES; Hay CM; Basgoz N; Yang OO
    Adv Exp Med Biol; 1998; 452():159-67. PubMed ID: 9889969
    [No Abstract]   [Full Text] [Related]  

  • 6. CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survival.
    Pollack H; Zhan MX; Safrit JT; Chen SH; Rochford G; Tao PZ; Koup R; Krasinski K; Borkowsky W
    AIDS; 1997 Jan; 11(1):F9-13. PubMed ID: 9110069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elite suppression of HIV-1 replication.
    Blankson JN; Siliciano RF
    Immunity; 2008 Dec; 29(6):845-7. PubMed ID: 19100698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8 lymphocytes in HIV infection: helpful and harmful.
    Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
    J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
    Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
    AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escape mutations in HIV infection and its impact on CD8+ T cell responses.
    López M; Soriano V; Benito JM
    Curr Mol Med; 2007 Aug; 7(5):446-58. PubMed ID: 17691959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.
    Bucy RP
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):223-7. PubMed ID: 10052752
    [No Abstract]   [Full Text] [Related]  

  • 13. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection.
    Mackewicz CE; Yang LC; Lifson JD; Levy JA
    Lancet; 1994 Dec; 344(8938):1671-3. PubMed ID: 7996961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 evolution and disease progression.
    Nowak MA; Anderson RM; Boerlijst MC; Bonhoeffer S; May RM; McMichael AJ
    Science; 1996 Nov; 274(5289):1008-11. PubMed ID: 8966557
    [No Abstract]   [Full Text] [Related]  

  • 17. CTL to HIV-1: surrogates or sirens.
    Mathieson BJ
    Nat Med; 1995 Apr; 1(4):304-5. PubMed ID: 7585057
    [No Abstract]   [Full Text] [Related]  

  • 18. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
    Geiben-Lynn R; Kursar M; Brown NV; Kerr EL; Luster AD; Walker BD
    J Virol; 2001 Sep; 75(17):8306-16. PubMed ID: 11483776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune control.
    Fornataro K; Jefferys R
    Body Posit; 1999 Mar; 12(3):9-12. PubMed ID: 11366299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.